Complementary Therapies can extend survival

Irish Cancer Society doesn’t inform us about the full range of Complementary Therapies that can help us overcome cancer.

 

What the Irish Cancer Society tells us:

Despite the benefits of Complementary Therapies, the Irish Cancer Society website only lists a dozen or so and gives no information about them.

What the Society doesn’t tell us:

What are Complementary therapies?
Complementary therapies are used in addition to your main treatment(s) and can be used to:

• Augment your main cancer treatment
• Reduce treatment side-effects

Categories:
• Increased Survival Time.
• Pain Reduction.
• Immune Boosters.
• Stress Reduction.
• Overall Wellbeing.
• Other

View a full list of Complementary therapies

The Irish Cancer Society gives no information about the following therapies which are known to extend patient survival time:

Antihistamines
Researchers have discovered antihistamines used to treat allergy have unique anti-cancer properties that are just now being recognized. It has been shown that the drug stops cancer cells being ´sticky´ and clumping together or sticking to organs and this could prevent new tumours forming and new metastatic spread.

It is particularly useful shortly before, during and after surgery to stop any threat of spread. In 2002 Clinical Trials of people having Colorectal surgery, 47 per cent did not survive 3 years. But with those taking Cimetidine, this figure fell to just 5 per cent. Swedish research showed that women with breast cancer who were coincidentally taking anti-histamines (such as Desloratidine or Loratidine) survived up to 50 per cent longer than those who weren´t.

Melatonin
Melatonin is a hormonal supplement of synthetic origin, but occasionally derived from animal sources. Melatonin is produced naturally in the body. Current evidence indicates that supplemental melatonin may positively influence tumor remission and survival of cancer patients, as well as protecting against side effects from anticancer treatment.

Metformin
Metformin, a drug used with Type-2 diabetes to lower serum glucose levels has been shown to be extremely helpful in cancer treatment. A meta-analysis of 20 research papers by Dr. Ming Yin et al in The Oncologist stated the metformin helped ‘increase survival times of patients’. Diabetics who take metformin are much less likely to develop cancer than those who don’t.

“the Irish Cancer Society…the leading provider of all information relating to cancer treatment…” Irish Cancer Society

Back to top

Please share this page